1. Home
  2. TTI vs AGIO Comparison

TTI vs AGIO Comparison

Compare TTI & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tetra Technologies Inc.

TTI

Tetra Technologies Inc.

HOLD

Current Price

$11.38

Market Cap

1.5B

Sector

Energy

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$27.41

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTI
AGIO
Founded
1981
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
1990
2013

Fundamental Metrics

Financial Performance
Metric
TTI
AGIO
Price
$11.38
$27.41
Analyst Decision
Strong Buy
Buy
Analyst Count
5
8
Target Price
$10.40
$36.25
AVG Volume (30 Days)
2.2M
943.3K
Earning Date
02-24-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
7085.43
N/A
EPS
0.92
N/A
Revenue
$618,755,000.00
$44,791,000.00
Revenue This Year
$5.43
$27.83
Revenue Next Year
$4.18
$133.46
P/E Ratio
$12.49
N/A
Revenue Growth
0.17
36.26
52 Week Low
$2.03
$22.24
52 Week High
$12.25
$46.00

Technical Indicators

Market Signals
Indicator
TTI
AGIO
Relative Strength Index (RSI) 60.48 45.61
Support Level $11.11 $26.25
Resistance Level $12.10 $29.93
Average True Range (ATR) 0.66 1.13
MACD -0.04 0.09
Stochastic Oscillator 60.96 31.79

Price Performance

Historical Comparison
TTI
AGIO

About TTI Tetra Technologies Inc.

Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. Majority of revenue is from Completion Fluids & Products. The company derives maximum revenue from United states.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: